81 related articles for article (PubMed ID: 10945950)
21. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection.
Wang H; DeVries ME; Deng S; Khandaker MH; Pickering JG; Chow LH; Garcia B; Kelvin DJ; Zhong R
Nat Med; 2000 May; 6(5):549-55. PubMed ID: 10802711
[TBL] [Abstract][Full Text] [Related]
22. Inosine improves islet xenograft survival in immunocompetent diabetic mice.
Schneider S; Klein HH
Eur J Med Res; 2005 Jul; 10(7):283-6. PubMed ID: 16055398
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
[No Abstract] [Full Text] [Related]
24. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse.
Nabeyama K; Yasunami Y; Toyofuku A; Nakano M; Satoh M; Matsuoka N; Ono J; Kamada M; Uede T; Todo S; Ikeda S
Transplantation; 2004 Dec; 78(11):1590-6. PubMed ID: 15591946
[TBL] [Abstract][Full Text] [Related]
27. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway.
Skaro AI; Liwski RS; Zhou J; Vessie EL; Lee TD; Hirsch GM
Cardiovasc Res; 2005 Jan; 65(1):283-91. PubMed ID: 15621057
[TBL] [Abstract][Full Text] [Related]
28. Immunoprotection of rat islet xenografts by cotransplantation with sertoli cells and a single injection of antilymphocyte serum.
Dufour JM; Rajotte RV; Kin T; Korbutt GS
Transplantation; 2003 May; 75(9):1594-6. PubMed ID: 12792521
[TBL] [Abstract][Full Text] [Related]
29. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma.
Sarvetnick N; Shizuru J; Liggitt D; Martin L; McIntyre B; Gregory A; Parslow T; Stewart T
Nature; 1990 Aug; 346(6287):844-7. PubMed ID: 2118234
[TBL] [Abstract][Full Text] [Related]
30. Recipient blood pre-transplant transfusion prolongs hepatic allograft survival in rats.
Wang FS; Yamaguchi Y; Furuhashi T; Uchino S; Kihara S; Yamada S; Mori K; Ogawa M
J Surg Res; 2006 Sep; 135(1):52-60. PubMed ID: 16716354
[TBL] [Abstract][Full Text] [Related]
31. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic islet transplantation into the bone marrow of the rat.
Salazar-Bañuelos A; Wright JR; Sigalet D; Benítez-Bribiesca L
Am J Surg; 2008 May; 195(5):674-8; discussion 678. PubMed ID: 18424287
[TBL] [Abstract][Full Text] [Related]
33. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
[No Abstract] [Full Text] [Related]
34. Prolongation of survival of donor-strain islet xenografts (rat-->mouse) by intrathymic inoculation of xenogeneic islet and bone marrow cells.
Mayo GL; Posselt AM; Barker CF; Rostami S; Mayo SP; Campos L; Naji A
Transplantation; 1994 Jul; 58(1):107-9. PubMed ID: 8036697
[No Abstract] [Full Text] [Related]
35. Islet xenograft rejection in absence of CD8+ T cells does not require either interferon-gamma or interleukin-5.
Crenier L; Le Moine A; Kiss R; Malaisse WJ; Goldman M
Transpl Immunol; 2002 May; 9(2-4):289-94. PubMed ID: 12180843
[TBL] [Abstract][Full Text] [Related]
36. Characterization of mononuclear infiltrates in rejecting and surviving murine islet allografts.
Serie JR; Goldberg JE; Pringle JA; Hegre OD
Transplant Proc; 1990 Apr; 22(2):814-5. PubMed ID: 2109408
[No Abstract] [Full Text] [Related]
37. Role of gamma-interferon in islet allograft rejection: class I MHC antigen induction.
Hao LM; Wang Y; Gill RG; La Rosa FG; Talmage DW; Lafferty KJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):2697-9. PubMed ID: 2495672
[No Abstract] [Full Text] [Related]
38. Importance of transplant site for prolongation of islet xenograft survival (rat to mouse) after low-temperature culture and cyclosporin A.
Kamei T; Yasunami Y; Terasaka R; Konomi K
Transplant Proc; 1989 Feb; 21(1 Pt 3):2693-4. PubMed ID: 2495670
[No Abstract] [Full Text] [Related]
39. Role of humoral immunity in pancreatic islet allo- and xenograft rejection.
Ahn M; Sohn C; Chang E; Chu G; DeMatteo RP; Barker CF; Markmann JF
Transplant Proc; 1996 Apr; 28(2):840-1. PubMed ID: 8623428
[No Abstract] [Full Text] [Related]
40. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice.
Desai NM; Bassiri H; Kim J; Koller BH; Smithies O; Barker CF; Naji A; Markmann JF
Transplantation; 1993 Apr; 55(4):718-22. PubMed ID: 8475541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
